HHATL and neuroblastoma: We found that the Hhatl expression is significantly downregulated in SH-SY5Y human neuroblastoma cells treated with TG (p = 1.964E-03) or TM (p = 3.685E-04) compared with control group (GSE24497) (Table S1).